From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria

Benzer Materyaller

• From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria
  Yazar:: Anna-Elisabeth Minder, MD, ve diğerleri
  Baskı/Yayın Bilgisi: (2026-02-01)
• Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria
  Yazar:: Anna-Elisabeth Minder, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-04-01)
• Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria
  Yazar:: Elena Di Pierro, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-01-01)
• New pharmacotherapies for the erythropoietic protoporphyrias: an analysis of trial protocols from a patient perspective
  Yazar:: Cornelia Dechant, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-12-01)
• Protection from phototoxic injury during laparoscopic surgery in patients with erythropoietic protoporphyria
  Yazar:: Konrad Pielaciński, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-06-01)